Hims & Hers Health, Inc. : Deutsche Bank Securities est neutre sur le titre

La recherche de Deutsche Bank Securities a confirmé son opinion sur le titre et reste à neutre. L’objectif de cours est abaissé de 31 USD à 25 USD.

This website stores some user agent data. These data are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to opt-out of any future tracking, a cookie will be set up in your browser to remember this choice for one year. I Agree, Deny
650